185 related articles for article (PubMed ID: 16679074)
1. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.
Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW
Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats.
Chung BD; Kayserili H; Ai M; Freudenberg J; Uzümcü A; Uyguner O; Bartels CF; Höning S; Ramirez A; Hanisch FG; Nürnberg G; Nürnberg P; Warman ML; Wollnik B; Kubisch C; Netzer C
Hum Mutat; 2009 Apr; 30(4):641-8. PubMed ID: 19177549
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia.
Saarinen A; Saukkonen T; Kivelä T; Lahtinen U; Laine C; Somer M; Toiviainen-Salo S; Cole WG; Lehesjoki AE; Mäkitie O
Clin Endocrinol (Oxf); 2010 Apr; 72(4):481-8. PubMed ID: 19673927
[TBL] [Abstract][Full Text] [Related]
4. Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men.
Crabbe P; Balemans W; Willaert A; van Pottelbergh I; Cleiren E; Coucke PJ; Ai M; Goemaere S; van Hul W; de Paepe A; Kaufman JM
J Bone Miner Res; 2005 Nov; 20(11):1951-9. PubMed ID: 16234968
[TBL] [Abstract][Full Text] [Related]
5. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
[TBL] [Abstract][Full Text] [Related]
6. Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.
Marques-Pinheiro A; Levasseur R; Cormier C; Bonneau J; Boileau C; Varret M; Abifadel M; Allanore Y
Joint Bone Spine; 2010 Mar; 77(2):151-3. PubMed ID: 20096619
[TBL] [Abstract][Full Text] [Related]
7. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
Narumi S; Numakura C; Shiihara T; Seiwa C; Nozaki Y; Yamagata T; Momoi MY; Watanabe Y; Yoshino M; Matsuishi T; Nishi E; Kawame H; Akahane T; Nishimura G; Emi M; Hasegawa T
Am J Med Genet A; 2010 Jan; 152A(1):133-40. PubMed ID: 20034086
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.
Hartikka H; Mäkitie O; Männikkö M; Doria AS; Daneman A; Cole WG; Ala-Kokko L; Sochett EB
J Bone Miner Res; 2005 May; 20(5):783-9. PubMed ID: 15824851
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism.
Cook FJ; Mumm S; Whyte MP; Wenkert D
J Bone Miner Res; 2014 Apr; 29(4):922-8. PubMed ID: 24014470
[TBL] [Abstract][Full Text] [Related]
10. Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome.
Lev D; Binson I; Foldes AJ; Watemberg N; Lerman-Sagie T
Isr Med Assoc J; 2003 Jun; 5(6):419-21. PubMed ID: 12841014
[TBL] [Abstract][Full Text] [Related]
11. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
[TBL] [Abstract][Full Text] [Related]
12. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.
Qin M; Hayashi H; Oshima K; Tahira T; Hayashi K; Kondo H
Hum Mutat; 2005 Aug; 26(2):104-12. PubMed ID: 15981244
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.
Streeten EA; McBride D; Puffenberger E; Hoffman ME; Pollin TI; Donnelly P; Sack P; Morton H
Bone; 2008 Sep; 43(3):584-90. PubMed ID: 18602879
[TBL] [Abstract][Full Text] [Related]
14. LRP5 gene polymorphisms and idiopathic osteoporosis in men.
Ferrari SL; Deutsch S; Baudoin C; Cohen-Solal M; Ostertag A; Antonarakis SE; Rizzoli R; de Vernejoul MC
Bone; 2005 Dec; 37(6):770-5. PubMed ID: 16168727
[TBL] [Abstract][Full Text] [Related]
15. Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene.
Okubo M; Horinishi A; Kim DH; Yamamoto TT; Murase T
Hum Mutat; 2002 Feb; 19(2):186. PubMed ID: 11793484
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.
Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O
Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437
[TBL] [Abstract][Full Text] [Related]
17. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).
Laine CM; Chung BD; Susic M; Prescott T; Semler O; Fiskerstrand T; D'Eufemia P; Castori M; Pekkinen M; Sochett E; Cole WG; Netzer C; Mäkitie O
Eur J Hum Genet; 2011 Aug; 19(8):875-81. PubMed ID: 21407258
[TBL] [Abstract][Full Text] [Related]
20. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women.
Ezura Y; Nakajima T; Urano T; Sudo Y; Kajita M; Yoshida H; Suzuki T; Hosoi T; Inoue S; Shiraki M; Emi M
Bone; 2007 Apr; 40(4):997-1005. PubMed ID: 17306638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
